Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Quantitative SPECT/CT for diagnosis of transthyretin amyloid cardiomyopathy: a pathology-based study
Tersalvi, G, Carey, P, Garmany, A, Scott, C G, Homb, A C, Hoffman, A C, Zhang, J, Davies, D R, Askew, J W, Dispenzieri, A, Grogan, M, Chareonthaitawee, P, Johnson, G B, Bois, M C, Abouezzeddine, O F, Tersalvi, Gregorio , Carey, Patricia , Garmany, Armin , Scott, Christopher G. , Homb, Andrew, Davies, Daniel R. , Askew, J. Wells , Dispenzieri, Angela , Grogan, M, Chareonthaitawee, Panithaya , Johnson, Geoffrey B , Bois, Melanie C. , AbouEzzeddine, Omar F.

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.304 Get It

Abstract Background 99mTc-labelled cardiac scintigraphy enables noninvasive diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Guidelines recommend using planar semiquantitative (heart to contralateral ratio, H/CL) and single photon emission computed tomography (SPECT) qualitative visual grading for diagnostic interpretation. However, planar imaging has inherent limitations, and visual grading is prone to interobserver variability, underscoring the need for standardized quantitative assessment. We developed a 3D volumetric quantitative score (3D Score) and assessed its diagnostic performance compared to myocardial tissue, the gold standard for ATTR-CM diagnosis. Methods At a single, tertiary referral center, we retrospectively identified consecutive patients from 06/2017 to 06/2024 who underwent 3-hour 99mTc-pyrophosphate or 99mTc-hydroxymethylene diphosphonate planar and SPECT/CT for suspected ATTR-CM and had archived myocardial tissue (biopsy or myectomy). On planar imaging, H/CL was calculated. On SPECT/CT, volumes of interest were drawn around the entire left ventricle (LV), avoiding calcifications, and within the right atrium (RA) blood pool. Mean uptake values were used to calculate the 3D Score (LVmean:RAmean), Fig 1A. Myocardial tissue was stained via sulfated Alcian blue and/or Congo red histochemistry. Once histologically confirmed, amyloid deposits were subtyped by liquid chromatography tandem mass spectrometry. The diagnostic performance of H/CL and 3D Score was assessed using receiver operating characteristic (ROC) curve analysis and predictive characteristics were defined. ROC areas under the curve (AUC) were compared using Delong test. Optimal cutoffs were determined using Youden’s J statistic. Baseline characteristics (demographics, echocardiogram, biomarkers) and H/CL were compared between patients above and below 3D Score cutoff. Results 239 patients were identified (median age 72 [65-78], 78% male, 46% ATTR positive). Median time between cardiac scintigraphy and myocardial tissue collection was 22 (6-65) days. Distribution of the 3D Score stratified by ATTR-CM status is illustrated in Fig 1B-C. The discriminative ability of the 3D Score was excellent (AUC 0.92) and superior to H/CL (0.87, p =0.006, Fig 1D-E). The optimal 3D Score cutoff for identifying ATTR-CM was ≥1.0 with sensitivity of 86%, specificity of 92%, positive predictive value (PPV) 90%, and negative predictive value (NPV) 89%. The optimal H/CL ratio cutoff for identifying ATTR-CM was ≥1.4 with sensitivity of 72%, specificity of 86%, PPV 81%, NPV 78%. Baseline characteristics of the overall cohort stratified by 3D Score are displayed in Table 1. Conclusions The 3D Score demonstrated excellent diagnostic performance for detecting ATTR-CM and was superior to current quantitative metrics. Future studies are needed to externally validate its performance across diverse patient cohorts and imaging centers and to investigate correlation with myocardial amyloid burden. Figure 1
Quantification of the biological stresses induced by healthy pregnancies using artificial intelligence interpretation of electrocardiograms
Carter, R, Johnson, P W, Wieczorek, M A, Bruce, C J, Adedinsewo, D A, Wieczorek, Mikolaj A. , Johnson, Patrick W. , Shufelt, Chrisandra , Bruce, Charles J.

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.4176 Get It

Abstract Background Artificial intelligence enhanced electrocardiograms (AI-ECG) have matured over the past 10 years. More recently, the AI-ECG estimate of biological sex has shown potential as a novel tool for cardiovascular risk stratification among women. Cardiovascular disease is a leading cause of pregnancy-related mortality; however, there have been limited approaches for estimating the physiological demands of pregnancy and its impact of maternal cardiovascular outcomes. Purpose To estimate pregnancy-related changes on AI-ECG-based sex and age estimation in a prospective cohort of otherwise healthy, complication free pregnant women. Methods This secondary analysis of the SPEC-AI Nigeria Clinical Trial identified pregnant women without any pregnancy-related complications (at baseline or during follow-up) who had at least two 12 lead ECGs recorded during the study. The ECGs were analyzed with previously-developed algorithms to predict age and biological sex. To address bias in the AI-ECG age estimate, a reference cohort of 25,144 healthy patients was analyzed using quantile regression to estimate the 75th percentile of the reference distribution as a function of age. The estimate of biological sex was used to determine a sex discordance score with a discordance of 0.2 considered clinically relevant. To simplify the trends in the data, the ECGs were categorized as during pregnancy (<=28 days prior to birth), peripartum (+/- 28 days of birth), and postpartum (28+ days after birth), and mixed effects models with a random intercept were used for analysis. Results A total of 207 females with a median age of 31 years (IQR 28 to 36 years) and normal blood pressures (systolic: 110 (IQR 10 to 120); diastolic: 70 (IQR 60-77); mmHg) were included from 5 clinical sites in Nigeria. The majority (73%, 150/207) of participants were in their second trimester at time of enrollment and the median number of ECGs per participant was 3 (max 7). The sex discordance score was elevated in 38% of the women at baseline and this percentage fell to 23% postpartum; which resulted in a decrease in the mean discordance score of 0.03 (95% CI: -0.06 to 0.0; p=0.028). Conversely, the percentage of patients with elevated age prediction increased from 35% to 41% over the course of pregnancy. This resulted in an increase in the bias-corrected AI-ECG age of 3.0 years (95% CI: 1.5 to 4.6 years; p<0.001). Conclusion This study demonstrates the preliminary utility of serial AI-ECG based assessment as a marker for the biological effects of pregnancy. The increase in sex discordance score during pregnancy may be related to changes in cardiac structure, such as increased ventricular mass and chamber dilation which often reverses postpartum. However, the impact on age estimation appeared to persist in the early postpartum period. Further study is warranted to associate any changes observed with long term maternal or fetal outcomes.Figure
Clinical impact of discordant stress test/angiography results: a sex-stratified analysis
Moerer, R, Sheriff, S Moideen, Johnson, P W, Wieczorek, M A, Carter, R E, Wieczorek, Mikolaj A. , Adedinsewo, Demilade , Moerer, Ryan T., Sheriff, Serin Moideen , Johnson, Patrick W.

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.1725 Get It

Abstract Background Ischemic heart disease is the leading cause of death among women. Non-obstructive coronary disease (NOCAD), often identified by a positive stress test and negative coronary angiogram result, is linked to adverse outcomes, particularly among women. Purpose This study evaluated the impact of discordant Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) stress test and coronary angiogram results on repeat invasive angiography and survival, while assessing sex-related differences. Methods Data were extracted from a single health system for patients who underwent a SPECT MPI stress test, and invasive coronary angiography performed within 3 months from September 2002 to July 2018. Discordance was defined as: Profile A – a positive stress test with negative angiography (epicardial coronary vessel stenosis <50%); Profile B – a negative stress test with positive angiography (at least one epicardial coronary vessel stenosis >=50%). To assess the association between discordance and all-cause mortality, Cox-proportional hazards regression was used to analyze the most recent stress/angiogram pair (adjusting for race, age, and number of prior angiograms). For repeat invasive angiography, where mortality was considered a competing event, the Fine-Gray proportional hazards model for the sub-distribution of a competing risk was used to analyze the first stress/angiogram pair (adjusting for race and age). Hazard ratios (HRs), sub-distribution hazard ratios (SHRs), and corresponding 95% confidence intervals (CIs) were reported. Results 5,179 were included in the final analysis, median age was 67.9 years and 32.7% were female. Approximately 15% and 24% were classified as Profile A and B respectively. Patients with a negative stress/negative angiogram were designated as the reference group. Profile A was not significantly associated with mortality or repeat invasive testing in both sexes. Profile B was associated with the highest risk of death (female aHR: 1.58, P<.001; male aHR: 1.54, P<.001) followed by those with a positive stress/positive angiogram (female aHR: 1.39, P=.009; male aHR: 1.25, P=.05) compared to the reference group. Profile B was significantly associated with repeat invasive testing and a stronger association was seen in females (female aSHR: 9.84, P< .001; male aSHR: 3.42, P<.001). A similar pattern was seen for those with a positive stress/positive angiogram. Conclusion Discordant Profile A showed no significant association with mortality or repeat invasive testing. Discordant Profile B was associated with the highest mortality risk in both sexes and showed a stronger association with repeat invasive testing among females. These findings underscore the importance of careful patient selection for stress testing, the need for improved stress testing options (especially in females), and prompt coronary evaluation in patients with a negative stress test and persistent symptoms or high-risk features.
Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients
Scalia, Isabel G., Farina, Juan M., Abdelnabi, Mahmoud H., Pietri, Milagros Pereyra, Ibrahim, Ramzi, Awad, Kamal, Abbas, Mohammed Tiseer , Ali, Nima Baba , Mahmoud, Ahmed K., Steidley, D. Eric, Masry, Hicham El , Sorajja, Dan , Scott, Luis R., Lee, Kwan, Johnson, D. W., Riad, Samy M. , Lester, Steven J., Jk, Oh, Ayoub, Chadi, Arsanjani, Reza, Farina, Juan M. , Ibrahim, Ramzi , Scalia, Isabel G. , Scalia, Isabel G , Farina, Juan M , Pereyra Pietri, Milagros, Pathangey, Girish , Ibrahim, Ramzi , Tiseer Abbas, Mohammed, Baba Ali, Nima , Alsidawi, Said , El Masry, Hicham , Sorajja, Dan , Scott, Luis R , Lee, Kwan S , Cho, Yeoungjee , Johnson, David W , Wadei, Hani M , Chao, Chieh-Ju , Mour, Girish K , Arsanjani, Reza , Abbas, Mohammed Tiseer , Pereyra, Milagros , Pathangey, Girish , Awad, Kamal , Mahmoud, Ahmed , Alsidawi, Said , Steidley, D. Eric , Scott, Luis R. , Cho, Yeoungjee , Wadei, Hani M. , Chao, Chieh‐Ju , Mour, Girish , Arsanjani, Reza

Mayo Clinic

Kidney360 | February 4, 2026 | Volume: 7 | Issue: 5 | Pages: 1128-1140

10.34067/kid.0000001063 | PMID 41637137 Get It

Key Points Atrial fibrillation after kidney transplantation is common and is associated with poor prognosis. Artificial intelligence applied to 12-lead electrocardiograms pretransplant accurately predicts the risk of new-onset atrial fibrillation in our cohort. High-risk artificial intelligence electrocardiography score was independently associated with increased risk of mortality and allograft failure. Background Incident atrial fibrillation (AF) is common after kidney transplantation (KTx) and is associated with worse clinical outcomes. Artificial intelligence electrocardiography (AI-ECG) algorithms have demonstrated efficacy in predicting risk of new-onset AF in the general population; however, their prognostic value in KTx recipients is relatively unknown. Methods Retrospective analysis was conducted on KTx recipients without AF, with at least one pretransplant ECG between 2011 and 2021 across three tertiary centers in the United States (Mayo Clinic sites in MN, AZ, and FL). A previously validated AI-ECG algorithm estimated the probability of incident AF for each patient. Based on AI-ECG probabilities, patients were categorized into high-risk and low-risk groups, with the optimal AI-ECG score cutoff determined. The incidence of new-onset AF, allograft failure, and mortality was compared between groups. Results Overall, 6246 patients (age 53.5±13.8 years; 58.9% male) were included. Pretransplant AI-ECG probability of AF ≥5% was the optimal cutoff for high risk of incident AF (sensitivity 72%, specificity 62%). High-risk scores were associated with true new-onset AF at 30 days (adjusted hazard ratio [aHR], 2.89; 95% confidence intervals [CI], 2.05 to 4.09; P < 0.001), 3 years (aHR, 2.54; 95% CI, 1.99 to 3.26, P < 0.001), and 5 years post-transplant (aHR, 2.48; 95% CI, 1.99 to 3.09, P < 0.001). High-risk AI-ECG scores were also associated with increased mortality (aHR, 1.56; 95% CI, 1.30 to 1.88, P < 0.001) and overall allograft failure (aHR, 1.50; 95% CI, 1.30 to 1.75, P < 0.001) through the 5-year follow-up. Conclusions This pretransplant AI-ECG parameter identified patients at increased risk of new-onset AF post-KTx and provided prognostic utility. Overall, this easy to obtain tool allows for risk stratification of patients who may benefit from closer monitoring, targeted risk factor modification, and early intervention.
American Medical Society for Sports Medicine Orthobiologics Toolkit for Sports Medicine Fellowships
Poindexter, Lauren K. , Nye, Nathaniel S., Romero, Joshua , Olufade, Oluseun A., Roh, Eugene Y. , Johnson, Shelby E. , Denq, William , Colbenson, Kristina M., Kruse, Ryan, Borg-Stein, Joanne, Romero, J. García , Colbenson, Kristina, Romero, Joshua M , Mautner, Kenneth , Olufade, Oluseun A., Kruse, Ryan C. , Shapiro, Shane A. , Borg‐Stein, Joanne

Mayo Clinic

Clinical Journal of Sport Medicine | February 4, 2026 | Volume: 36 | Issue: 2 | Pages: 185-194

10.1097/jsm.0000000000001418 | PMID 41636515 Get It

Objective: Orthobiologics are increasingly sought-after interventions in sports medicine for treatment of musculoskeletal injuries and conditions. Despite this trend, differences exist across sports medicine fellowship programs regarding foundational knowledge, educational curricula, and practical experience with orthobiologic therapies (eg, platelet-rich plasma, bone marrow aspirate concentrate, microfragmented adipose tissue). This represents an important educational gap for those training in sports medicine fellowships. To address this gap, an educational toolkit was envisioned with the sports medicine fellowship director and trainee in mind. Data Sources: Collective observations from physician experts in sports medicine education established the variations in curricula and expertise of graduating fellows. A literature review was conducted to source English-language peer reviewed articles from the online PubMed database. The scope of this project did not include an independent systematic analysis or statistical assessments. Main Results: An educational toolkit consisting of 12 adaptable modules was developed, each with a suggested reading list from the published literature. The modules may be rearranged to support each program's learning schedule. The information and lessons contained herein may be valuable to all healthcare providers interested in the evidence-based application of orthobiologics and insightful interpretation of related research. Conclusions: By implementing an educational toolkit, sports medicine fellowships may improve the quality of education on orthobiologics. This is intended to improve the knowledge and skill set of fellowship graduates, thus promoting the scientific, responsible use of orthobiologic interventions.
Quantitative bias analyses to address measurement error in time-to-event endpoints
Ackerman, Benjamin , Gan, Ryan W. , Zhang, Youyi, Hayden, Jennifer, Wang, Jocelyn R., Meyer, Craig S. , Lund, Jennifer L., Schneeweiss, S, Roose, James , Nadeem, Omar, NS, Raje, Giri, Smith, Hester, Laura , Brayer, Jason , Batavia, Ashita S. , Schneeweiß, Sebastian , Lund, Jennifer L , Schneeweiss, Sebastian , Stürmer, Til , Siddique, Juned , Weberpals, Janick G. , Nadeem, Omar , Ailawadhi, Sikander

Mayo Clinic

American Journal of Epidemiology | February 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/aje/kwag027 | PMID 41645621 Get It

Abstract When using real-world data to construct an external comparator arm for a single-arm trial, there may be differences in how and when patients are assessed for disease between trial and real-world settings. Such differences can generate outcome measurement error when comparing time-to-event endpoints and lead to biased findings. Recent methods have been developed to mitigate measurement error bias in real-world endpoints; however, they rely on the existence of a validation sample, ie, data on a set of patients where both the “true” trial-like and “mis-measured” real-world measures are collected. We demonstrate how novel statistical methods can be leveraged as quantitative bias analyses (QBA) to contextualize real-world evidence findings when outcome measurement error is of concern, but validation samples are infeasible to collect. Quantitative bias analyses allow researchers to set plausible ranges for the amount of error when not directly measurable. We highlight how to conduct QBA with two recent methods, cumulative incidence curve correction and survival regression calibration, and illustrate how to generate plausible parameter values through simulation. We provide an illustrative QBA example in a cohort of real-world patients with newly diagnosed multiple myeloma and provide practical guidance to apply QBA for outcome measurement error and interpret results.
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomas
Lin, Wan-Hsin, Kosari, Farhad , Smadbeck, James B. , Barrett, Michael T. , Feathers, Ryan, Hall, Jamie, Sadeghian, Dorsay , Johnson, Sarah H. , Harris, Faye R. , Berry, Taylor, McCune, Alexa, Murphy, Stephen James, Kinsella, Lindsey, Ensign, Shannon P. Fortin, Yang, Lin , Emanuel, Angela, Jones, Leila A., Schaefer-Klein, Janet, Ida, Cristiane M., Sherman, Wendy, Porter, Alyx B. , Rosenfeld, Steven, Kizilbash, Sani H., Jaeckle, Kurt A. , Mrugala, Maciej M., Borad, Mitesh, Bendok, Bernard R., Quiñones-Hinojosa, A., Cheville, John C. , Vasmatzis, George , Anastasiadis, Panos Z. , Ensign, Shannon P. Fortin , Mansfield, Aaron S , Ensign, Shannon P. Fortin , Sotiriou, Sotiris , Haydu, Lauren E. , Moniz‐Garcia, Diogo , Ida, Cristiane M., Salomao, Marcela , Kizilbash, Sani H. , Mrugala, Maciej M., Mansfield, Aaron S. , Borad, Mitesh J. , Bendok, Bernard R. , Burns, Terry C. , Quiñones‐Hinojosa, Alfredo

Mayo Clinic

No container title available | February 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.02.01.701806 | PMID 41676502 Get It

Abstract High-grade gliomas (HGGs) are aggressive tumors with poor outcomes and limited treatment options. Here, we combined genomic and transcriptomic tumor profiling with drug testing in a patient-derived 3-dimensional culture model to identify individualized treatments and predictive biomarkers. Activity of single agents targeting frequently dysregulated glioma pathways was relatively poor ex vivo and generally reflected historical patient data. However, compounds targeting PI3K, epigenetic, and survival/senescence signaling were effective in some cases. Drug sensitivity correlated with transcriptional rather than genomic features and suggested heterogeneity as a resistance mechanism. Bromodomain and extraterminal domain inhibition was particularly effective in tumors enriched in the mesenchymal transcriptional subtype, promoted proneural transition, and was overcome by upregulated PI3K signaling. Notably, combinations were largely effective, with 6 strategies exhibiting stronger efficacy than corresponding single agents in most cases (58-77%). This study identifies HGG vulnerabilities and associated biomarkers, resistance mechanisms, and effective combination strategies that warrant further clinical validation. Graphical Abstract
Relationship between age and severity of cognitive impairment at diagnosis for early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI
Hammers, Dustin B., Eloyan, Ani, Thangarajah, Maryanne, Taurone, Alexander, Gao, Sujuan, Beckett, Laurel, Kirby, Kala, Dage, Jeffrey L., Nudelman, Kelly, Aisen, Paul, Reman, Rema, Vemuri, Prashanthi, Joie, Renaud La, Touroutoglou, Alexandra, Atri, Alireza, Clark, David, Day, Gregory S., Duara, Ranjan, Graff‐Radford, Neill R., Honig, Lawrence S., Jones, D., Masdeu, Joseph C. , Mendez, Mario F., Womack, Kyle, Musiek, Erik, Onyike, Chiadi U., Riddle, Meghan, Grant, Ian, Rogalski, Emily, Johnson, Erik C. B., Salloway, Steven, Sha, Sharon J. , Turner, Raymond Scott, Wingo, Thomas S., Wolk, David A., Carrillo, Marı́a C., Dickerson, Bradford C., Rabinovici, Gil D., Apostolova, Liana G., Initiative, for the Alzheimer's Disease Neuroimaging, Carrillo, María C. , Rabinovici, Gil D. , Joie, Renaud La , Day, Gregory S. , Day, Gregory S , La Joie, Renaud , Rabinovici, Gil D , Hammers, Dustin B , Eloyan, Ani , Taurone, Alexander, Gao, Sujuan , Beckett, Laurel , Dage, Jeffrey L. , Nudelman, Kelly , Aisen, Paul , Reman, Rema, Vemuri, Prashanthi , Touroutoglou, Alexandra , Atri, Alireza , Clark, David, Duara, Ranjan , Graff‐Radford, Neill R. , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Mendez, Mario F. , Musiek, Erik , Onyike, Chiadi U. , Riddle, Meghan , Johnson, Erik C. B. , Salloway, Steve , Turner, Raymond Scott , Wolk, David A. , Dickerson, Bradford Clark , Apostolova, Liana G. , Initiative, for the Alzheimer’s Disease Neuroimaging

Mayo Clinic

Alzheimer's & Dementia | January 30, 2026 | Volume: 22 | Issue: 2 | Pages: No page available

10.1002/alz.71160 | PMID 41614286 Get It

INTRODUCTION Recent work has identified unique cognitive profiles for early‐onset Alzheimer's disease (EOAD) relative to late‐onset Alzheimer's disease (LOAD), however, examination has been limited in determining whether the association between age and cognitive severity at presentation also differs across conditions. METHODS A series of linear spline regression models was conducted across baseline cognitive data from 325 EOAD and 314 LOAD participants, after accounting for education, sex, and apolipoprotein ε4 status. RESULTS Significant differences existed in the relationship between baseline age and cognitive performance between EOAD and LOAD samples for Processing Speed/Attention, Executive Functioning, and Episodic Immediate Memory. Younger participants from both EOAD and LOAD groups performed disproportionately worse on non‐amnestic cognitive domains, with this occurring to a greater extent in EOAD than LOAD. DISCUSSION In the age of disease‐modifying treatments, results highlight the importance of assessing for cognitive declines in individuals starting much earlier than age 65. Highlights Early‐onset Alzheimer's disease (EOAD) and late‐onset Alzheimer's disease (LOAD) participants each displayed cognitive impairments relative to same‐aged peers across most domains. Both groups displayed positive relationships between impairment among non‐amnestic cognitive domains and baseline age. This relationship displayed a significantly greater effect in EOAD than LOAD, with domains of Processing Speed/Attention and Executive Functioning skills being the most pronounced. Of those participants developing AD, age displayed a disproportionate impact on their symptom onset.
Abstract DP331: Automated Identification of Retinal Vascular Biomarkers in the Field using a Mobile Laboratory and Portable Fundus Cameras
Huentelman, Matthew, Johnson, Megan , Song, Serena , Price, Calla, Barraza, Yareli, Ryan, Lee, Dumitrascu, Oana, Ryan, Lee , Wang, Yalin

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.dp331 Get It

Objective: To assess the link between retinal vascular health and cognitive performance in a diverse population, using a novel mobile laboratory platform and portable color fundus photography. Background: The retina is an accessible window into brain health. Studies that had highlighted the link between retinal vasculature and cognition included clinical populations or narrowly defined research cohorts, with limited generalizability. To address the need to expand this research to demographic and geographic diverse communities, we launched a mobile laboratory platform across rural and urban Arizona zip codes. Methods: 240 subjects were recruited in our prospective community-based study. We assessed cognition using the MindCrowd web-based testing platform and analyzed verbal paired associates (VPA) task, a validated measure of verbal associative memory sensitive to age-related cognitive decline. Non-mydriatic color fundus photographs were obtained using the portable hand-held Aurora camera (Optomed), two images per eye (disc- and macula-centered). Image processing and vascular feature quantification were automatically conducted using Automorph software. Linear regression models examined the associations between retinal vascular metrics and VPA, adjusting for age, sex, education attainment, and risk factors. Results: Our cohort’s mean age was 45 +/-16.7 years, 32.9% were male and 39.5% had a college degree. In disc-centered fundus images, fractal dimension strongly associated with chronological age (p = 1.04E-10). Greater artery tortuosity in the retinal zones B and C was associated with lower VPA (p = 0.02 and p = 0.004, respectively). In macula-centered images, fractal dimension showed the strongest association with age (p = 4.31E-11), reinforcing its utility as a robust biomarker of vascular aging. Males had wider average artery caliber in zone B (p=0.02). Zone B vein fractal dimension (p=0.002) and vein vessel density (p=0.006) were the strongest predictors of VPA. Conclusions: This study demonstrates the safety, feasibility, and utility of a mobile laboratory to collect high-quality non-mydriatic color photos and cognitive data across a geographically diverse cohort. Arterial tortuosity and venous fractal dimension and density, particularly in retinal zone B, were predictive of cognitive performance, after adjusting for vascular health covariates. Retina may become a scalable and accessible platform for studying brain aging in the general population.
Outcomes Among Drug Refractory Patients With Atrial Fibrillation (AF) and Concomitant Heart Failure With Preserved Ejection Fraction (HFpEF) Treated With Catheter Ablation Versus Antiarrhythmic Drugs
Deshmukh, Abhishek J., Karim, Saima , Khaled, Alia , Rong, Yiran , Batul, Syeda Atiqa, Batul, Syeda Atiqa , Deshmukh, Abhishek , Khanna, Rahul, Batul, Syeda Atiqa

Mayo Clinic

Journal of Cardiovascular Electrophysiology | January 29, 2026 | Volume: 37 | Issue: 4 | Pages: 724-732

10.1111/jce.70250 | PMID 41606998 Get It

ABSTRACT Introduction Heart failure with preserved ejection fraction (HFpEF) accounts for about half of the cases of heart failure. HFpEF and atrial fibrillation (AF) often coexist and share similar risk factors. The objective of this study is to examine the differences in risk of clinical outcomes among drug refractory AF patients with concomitant HFpEF treated with catheter ablation (CA) versus antiarrhythmic drugs (AADs). Methods Using the Optum PanTher Electronic Health Record (EHR) database, adult HF patients with left ventricular ejection fraction (LVEF) ≥ 50% and an AF diagnosis with a history of AAD prescription between January 2014 and March 2021 were identified. Patients were classified into CA or AAD groups based on their subsequent treatment for AF. The primary outcome of interest included a composite of AF/atrial flutter (AFL)/atrial tachycardia‐related inpatient admissions and electrical cardioversions in the 57–730 days post‐index treatment period (follow‐up extended to 1095 days for sub‐analysis). Overall HF‐related admissions and systolic HF‐related admissions were assessed as secondary outcomes. Inverse probability of treatment weighting (IPTW) of propensity scores was used to balance the two cohorts on study covariates. Cox regression analyses were performed to examine outcomes in the covariate‐balanced cohorts. Results The final sample included 586 CA and 1436 AAD patients. The cohorts were well balanced on patient demographics and clinical characteristics after applying IPTW. Patients treated with CA had a significantly lower rate of primary composite outcome as compared to those treated with AADs (15.4% vs. 24.9%, log‐rank p test = 0.001). Cox model revealed a 34% lower risk of atrial arrhythmia related admissions and cardioversion among patients treated with CA versus AADs in the 57–730 days post‐index treatment period (Hazard ratio [HR] 0.66, 95% confidence interval [CI] 0.50–0.87, p = 0.003). There were no significant differences in HF and systolic HF‐related admissions between the two groups (except in the subgroup analysis of patients < 70 years of age, patients with paroxysmal AF, and patients with persistent AF). Similar results were observed in sub‐analyses with 57–1095 days of follow‐up. Conclusion Among drug refractory AF patients with concomitant HFpEF, CA was shown to reduce the risk of recurrent arrhythmias as compared to AAD continuation.